Medtronic is facing a federal antitrust lawsuit from rival medical device manufacturer Lexington Medical Inc., which alleges the company has used restrictive contracts, bundled pricing and barriers to competing product trials to maintain its dominance in the U.S. surgical stapler market.
The lawsuit, filed Nov. 5 in federal court in Massachusetts, accuses Medtronic of leveraging its extensive portfolio of surgical equipment to discourage hospitals from purchasing competing devices, according to a Nov. 6 report by Erik Uebelacker of Courthouse News Service.
Lexington, a Massachusetts-based medical equipment manufacturer, alleges Medtronic controls more than 90% of the market for laparoscopic surgical staplers, devices used to cut and seal tissue during minimally invasive procedures.
The 63-page complaint contends that Medtronic’s contracting practices have prevented hospitals from evaluating alternative products, limiting competition even when rival devices demonstrate better clinical performance.
The allegations have not been adjudicated in the new case.
Hospital Contracts at Center of Dispute
Lexington’s lawsuit focuses on Medtronic’s relationships with hospitals, alleging that purchasing agreements covering multiple categories of surgical equipment effectively discourage customers from switching suppliers.
According to Courthouse News Service, Lexington claims Medtronic links financial incentives, including discounts and rebates, to hospital purchases across several product lines. These arrangements allegedly make it financially difficult for hospitals to adopt competing staplers without jeopardizing favorable pricing on other medical devices.
Lexington also alleges that Medtronic uses multiyear agreements to preserve its market position and restrict opportunities for competing manufacturers to demonstrate their products.
The complaint cites internal company materials that Lexington says reveal efforts to discourage hospitals from conducting trials involving rival equipment.
The lawsuit also references public and internal statements attributed to Medtronic executives concerning the durability of the company’s customer contracts, according to the Courthouse News report.
Lexington argues that the combined effect of these practices extends beyond its own commercial prospects, potentially increasing hospital purchasing costs and reducing incentives for medical device innovation.
Lexington Claims Superior Product Performance
Lexington manufactures the AEON Endoscopic Stapling System, which competes with Medtronic’s products in minimally invasive surgery.
The company maintains that its technology could gain greater market acceptance if hospitals were able to evaluate competing staplers without contractual restrictions.
Related: Medtronic Slapped With $382M Antitrust Verdict in Bundling Case
According to the Courthouse News report, Lexington cited a comparative hospital evaluation in which its AEON device was rated clinically superior to a competing Medtronic product in 89% of cases.
That performance claim comes from Lexington’s complaint and has not been independently established in the reporting.
The company argues that Medtronic’s market position is sustained by purchasing restrictions rather than product quality alone.
The dispute highlights the commercial importance of hospital procurement arrangements in the medical device industry, where purchasing decisions can involve several categories of equipment and long-term supplier relationships.
Earlier $382 Million Verdict Adds Legal Pressure
The latest lawsuit follows a separate antitrust dispute involving Medtronic and Applied Medical Resources Corp., another manufacturer of surgical equipment.
In that case, a jury found that Medtronic had engaged in unlawful bundling practices involving its LigaSure vessel-sealing technology, according to Courthouse News Service.
The litigation resulted in a $382 million damages award against Medtronic.
Lexington’s complaint draws on materials disclosed during the Applied Medical proceedings to support its allegations about Medtronic’s sales practices and hospital contracting strategy.
The earlier verdict concerned a different category of surgical devices and does not establish liability in Lexington’s newly filed lawsuit.
Medtronic has previously faced other competition-related litigation. In 2010, CareFusion Corp. accused the company of anticompetitive behavior involving treatments for vertebral fractures. That case was dismissed the same year, according to Courthouse News Service.
Lawsuit Seeks Damages and Contracting Restrictions
Lexington is pursuing claims under the federal Sherman Antitrust Act and Massachusetts competition law.
The company is seeking unspecified monetary damages and a court order preventing Medtronic from entering into agreements found to unlawfully exclude competitors.
Such relief could affect the company’s contracting practices if Lexington ultimately prevails.
Medtronic representatives did not immediately respond to requests for comment from Courthouse News Service at the time of its Nov. 6 report. No subsequent company response has been independently verified for this article.
The case, Lexington Medical, Inc. v. Medtronic, Inc., was filed in the U.S. District Court for the District of Massachusetts under case number 1:26-cv-14981.
Source: Courthouse News Service
